See more : Immutable Holdings Inc. (IHLDF) Income Statement Analysis – Financial Results
Complete financial analysis of Third Harmonic Bio, Inc. (THRD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Third Harmonic Bio, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- IPD Group Limited (IPG.AX) Income Statement Analysis – Financial Results
- Corteva, Inc. (CTVA) Income Statement Analysis – Financial Results
- Boart Longyear Group Ltd. (BLY.AX) Income Statement Analysis – Financial Results
- Rossari Biotech Limited (ROSSARI.BO) Income Statement Analysis – Financial Results
- Generation Mining Limited (GENM.TO) Income Statement Analysis – Financial Results
Third Harmonic Bio, Inc. (THRD)
About Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 35.00K | 38.00K | 0.00 | 0.00 |
Gross Profit | -35.00K | -38.00K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 23.96M | 24.41M | 15.75M | 9.95M |
General & Administrative | 19.99M | 13.30M | 3.26M | 1.17M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 19.99M | 13.30M | 3.26M | 1.17M |
Other Expenses | 0.00 | 2.55M | -10.61M | -1.69M |
Operating Expenses | 43.92M | 37.71M | 19.00M | 11.12M |
Cost & Expenses | 43.95M | 37.71M | 19.00M | 11.12M |
Interest Income | 13.13M | 2.55K | 5.00 | 0.00 |
Interest Expense | 0.00 | 2.55M | 0.00 | 0.00 |
Depreciation & Amortization | 35.00K | 38.00K | 19.00M | 11.12M |
EBITDA | -30.79M | -35.12M | -10.61M | -1.69M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -43.95M | -37.71M | -19.00M | -11.12M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 13.13M | 2.55M | -10.61M | -1.69M |
Income Before Tax | -30.82M | -35.16M | -29.61M | -12.81M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 2.55M | -19.00K | -1.00K |
Net Income | -30.82M | -37.71M | -29.61M | -12.81M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.78 | -0.96 | -0.77 | -0.33 |
EPS Diluted | -0.78 | -0.96 | -0.77 | -0.33 |
Weighted Avg Shares Out | 39.65M | 39.38M | 38.69M | 38.69M |
Weighted Avg Shares Out (Dil) | 39.65M | 39.38M | 38.69M | 38.69M |
National Penn Bancshares, Inc. Receives Regulatory Approvals for TF Financial Corporation Merger
INVESTOR ALERT – TF Financial Corporation: The Law Offices of Vincent Wong Investigates the Sale of TF Financial Corporation – THRD
Faruqi & Faruqi, LLP is Investigating TF Financial Corporation and its Board of Directors in Connection With the Proposed Sale of the Company to National Penn Bancshares
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of TF Financial Corporation In Connection With The Proposed Sale Of The Company To National Penn Bancshares
EQUITY ALERT: The Rosen Law Firm Announces Investigation of TF Financial Corporation (THRD) Concerning the Proposed Acquisition by National Penn Bancshares, Inc. (NPBC)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of TF Financial Corporation and Its Board of Directors In Connection With the Sale of the Company to National Penn Bancshares -- THRD
TF FINANCIAL CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of TF Financial Corporation and Its Board of Directors In Connection With the Sale of the Company to National Penn Bancshares
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of TF Financial Corporation In Connection With The Proposed Sale Of The Company To National Penn Bancshares
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of TF Financial Corporation Stockholders
Source: https://incomestatements.info
Category: Stock Reports